CCS
IPXL

Crosspoint Capital Strategies’s Impax Laboratories, Inc. IPXL Stock Holding History

Crosspoint Capital Strategies’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-50
Closed -$2K – 1289
2015
Q3 		$2K Buy
+50
New +$2K ﹤0.01% 628